[
    [
        {
            "time": "",
            "original_text": "甘李药业明日申购，发行价63.32元/股，冲击胰岛素第一股胜算几何？",
            "features": {
                "keywords": [
                    "甘李药业",
                    "申购",
                    "发行价",
                    "胰岛素",
                    "第一股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "甘李药业明日申购，发行价63.32元/股，冲击胰岛素第一股胜算几何？",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "甘李药业上市首日大涨44%，市值已超通化东宝！",
            "features": {
                "keywords": [
                    "甘李药业",
                    "上市首日",
                    "大涨",
                    "市值",
                    "通化东宝"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "甘李药业上市首日大涨44%，市值已超通化东宝！",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "凯莱英(002821)：与高瓴签署附条件生效战略合作协议 增量订单不低于8亿元",
            "features": {
                "keywords": [
                    "凯莱英",
                    "高瓴",
                    "战略合作协议",
                    "增量订单",
                    "8亿元"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯莱英(002821)：与高瓴签署附条件生效战略合作协议 增量订单不低于8亿元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]